RETA insider filings
REATA PHARMACEUTICALS INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-09-28. Screen RETA transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for RETA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — REATA PHARMACEUTICALS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-09-28 | 4 | Desai Antal Rohit — Director, 10% owner CPMG Inc — Director, 10% owner | Disposition to issuer (D): 31,467 · Disposition to issuer (D): 113 · Disposition to issuer (D): 116,512 · Disposition to issuer (D): 282,246 · Disposition to issuer (D): 137,962 · Disposition to issuer (D): 5,464 · +18 more | EDGAR |
| 2023-09-26 | 4 | McGaughy R Kent Jr — Director, 10% owner | Disposition to issuer (D): 25,004 · Disposition to issuer (D): 2,896,901 · Disposition to issuer (D): 4,591 · Disposition to issuer (D): 280 · Disposition to issuer (D): 1,692,857 (derivative) · Disposition to issuer (D): 51,095 (derivative) · +19 more | EDGAR |
| 2023-09-26 | 4 | Oliger Christy J. — Director | Disposition to issuer (D): 5,565 · Disposition to issuer (D): 1,250 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 106 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 180 (derivative) · +2 more | EDGAR |
| 2023-09-26 | 4 | Bir Dawn Carter — Chief Commercial Officer | Disposition to issuer (D): 33,805 · Disposition to issuer (D): 16,500 (derivative) · Disposition to issuer (D): 70,000 (derivative) · Disposition to issuer (D): 63,650 (derivative) · Disposition to issuer (D): 71,300 (derivative) · Disposition to issuer (D): 34,500 (derivative) · +3 more | EDGAR |
| 2023-09-26 | 4 | Loewen Andrea — SVP, Global Regulatory Affairs | Disposition to issuer (D): 28,416 · Disposition to issuer (D): 11,250 (derivative) · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 47,738 (derivative) | EDGAR |
| 2023-09-26 | 4 | Soni Manmeet Singh — COO, CFO and President | Disposition to issuer (D): 62,621 · Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 95,475 (derivative) · Disposition to issuer (D): 175,000 (derivative) · +2 more | EDGAR |
| 2023-09-26 | 4 | Ruff Shamim — Director | Disposition to issuer (D): 7,359 · Disposition to issuer (D): 3,334 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 780 (derivative) · Disposition to issuer (D): 443 (derivative) · Disposition to issuer (D): 1,405 (derivative) · +2 more | EDGAR |
| 2023-09-26 | 4 | Meyer Colin John — Chief Innovation Officer | Disposition to issuer (D): 81,633 · Disposition to issuer (D): 74,304 (derivative) · Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 70,000 (derivative) · Disposition to issuer (D): 95,475 (derivative) · +6 more | EDGAR |
| 2023-09-26 | 4 | Patni Rajiv — EVP, Chief R&D Officer | Disposition to issuer (D): 45,000 · Disposition to issuer (D): 90,000 (derivative) | EDGAR |
| 2023-09-26 | 4 | Ryder Steven — Director | Disposition to issuer (D): 10,907 · Disposition to issuer (D): 1,322 (derivative) · Disposition to issuer (D): 6,038 (derivative) · Disposition to issuer (D): 5,492 (derivative) · Disposition to issuer (D): 441 (derivative) · Disposition to issuer (D): 2,137 (derivative) | EDGAR |
| 2023-09-26 | 4 | Huff James Warren — Chief Executive Officer, Director | Disposition to issuer (D): 122,480 · Disposition to issuer (D): 10,398 · Disposition to issuer (D): 212,903 (derivative) · Disposition to issuer (D): 23,968 (derivative) · Disposition to issuer (D): 275,436 (derivative) · Disposition to issuer (D): 146,824 (derivative) · +7 more | EDGAR |
| 2023-09-26 | 4 | McClellan William D. Jr. — Director | Disposition to issuer (D): 6,017 · Disposition to issuer (D): 6,300 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 99 (derivative) · Disposition to issuer (D): 416 (derivative) · Disposition to issuer (D): 5,620 (derivative) · +6 more | EDGAR |
| 2023-09-26 | 4 | Edwards Martin — Director | Disposition to issuer (D): 6,116 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 6,300 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 99 (derivative) · Disposition to issuer (D): 520 (derivative) · +3 more | EDGAR |
| 2023-09-26 | 4 | Anand Bhaskar — SVP, Chief Accounting Officer | Disposition to issuer (D): 24,089 · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 23,438 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 33,500 (derivative) | EDGAR |
| 2023-09-26 | 4 | ROSE WILLIAM — Director | Disposition to issuer (D): 379,281 · Disposition to issuer (D): 11,618 · Disposition to issuer (D): 19,795 · Disposition to issuer (D): 7,886 · Disposition to issuer (D): 20 · Disposition to issuer (D): 45 · +25 more | EDGAR |
| 2023-09-26 | 4 | WORTLEY MICHAEL D — Chief Legal Officer | Disposition to issuer (D): 49,701 · Disposition to issuer (D): 16,500 (derivative) · Disposition to issuer (D): 70,000 (derivative) · Disposition to issuer (D): 63,650 (derivative) · Disposition to issuer (D): 62,800 (derivative) · Disposition to issuer (D): 60,400 (derivative) · +4 more | EDGAR |
| 2023-09-19 | 4 | ROSE WILLIAM — Director | Gift (G): 29,000 (derivative) @ $0 · Gift (G): 29,000 (derivative) @ $0 · Gift (G): 29,000 (derivative) @ $0 · Gift (G): 29,000 (derivative) @ $0 · Gift (G): 29,000 (derivative) @ $0 · Gift (G): 29,000 (derivative) @ $0 · +2 more | EDGAR |
| 2023-09-18 | 4 | Loewen Andrea — SVP, Global Regulatory Affairs | Sale (S): 3,175 @ $172.03 | EDGAR |
| 2023-09-07 | 4 | Anand Bhaskar — SVP, Chief Accounting Officer | Sale (S): 406 @ $169.20 | EDGAR |
| 2023-08-24 | 4 | ROSE WILLIAM — Director | Gift (G): 500,000 @ $0 | EDGAR |
| 2023-08-17 | 4 | Soni Manmeet Singh — COO, CFO and President | Sale (S): 1,755 @ $168.41 | EDGAR |
| 2023-08-17 | 4 | Meyer Colin John — Chief Innovation Officer | Sale (S): 2,144 @ $169.07 · Sale (S): 596 @ $168.74 | EDGAR |
| 2023-08-17 | 4 | Bir Dawn Carter — Chief Commercial Officer | Sale (S): 807 @ $169.04 · Sale (S): 398 @ $168.33 | EDGAR |
| 2023-08-17 | 4 | Anand Bhaskar — SVP, Chief Accounting Officer | Sale (S): 193 @ $169.06 · Sale (S): 210 @ $168.42 | EDGAR |
| 2023-08-17 | 4 | WORTLEY MICHAEL D — Chief Legal Officer | Sale (S): 807 @ $169.04 · Sale (S): 398 @ $168.76 | EDGAR |
| 2023-08-01 | 4 | Soni Manmeet Singh — COO, CFO and President | Conversion (C): 75,000 · Sale (S): 75,000 @ $164.62 · Option exercise (M): 75,000 (derivative) @ $0 · Option exercise (M): 75,000 (derivative) @ $72.70 · Conversion (C): 75,000 (derivative) | EDGAR |
| 2023-08-01 | 4 | Ruff Shamim — Director | Option exercise (M): 1,250 @ $92.20 · Option exercise (M): 6,666 @ $92.20 · Option exercise (M): 319 @ $92.20 · Sale (S): 8,235 @ $164.53 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 6,666 (derivative) @ $0 · +1 more | EDGAR |
| 2023-08-01 | 4 | McClellan William D. Jr. — Director | Conversion (C): 5,000 · Sale (S): 5,000 @ $164.49 · Option exercise (M): 5,000 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $26.46 · Conversion (C): 5,000 (derivative) | EDGAR |
| 2023-08-01 | 4 | Bir Dawn Carter — Chief Commercial Officer | Conversion (C): 40,000 · Sale (S): 40,000 @ $164.54 · Option exercise (M): 40,000 (derivative) @ $0 · Option exercise (M): 40,000 (derivative) @ $22.57 · Conversion (C): 40,000 (derivative) | EDGAR |
| 2023-07-10 | 4 | Soni Manmeet Singh — COO, CFO and President | Grant/award (A): 6,000 @ $0 | EDGAR |
| 2023-07-10 | 4 | Meyer Colin John — Chief Innovation Officer | Grant/award (A): 6,000 @ $0 | EDGAR |
| 2023-07-10 | 4 | Bir Dawn Carter — Chief Commercial Officer | Grant/award (A): 4,125 @ $0 | EDGAR |
| 2023-07-10 | 4 | Huff James Warren — Chief Executive Officer, Director | Grant/award (A): 11,656 @ $0 · Grant/award (A): 72,564 @ $0 · Grant/award (A): 275,436 (derivative) @ $0 | EDGAR |
| 2023-07-10 | 4 | WORTLEY MICHAEL D — Chief Legal Officer | Grant/award (A): 4,125 @ $0 | EDGAR |
| 2023-06-16 | 4 | Anand Bhaskar — SVP, Chief Accounting Officer | Option exercise (M): 1,562 @ $27.32 · Sale (S): 2,343 @ $102.11 · Option exercise (M): 1,562 (derivative) @ $0 | EDGAR |
| 2023-06-14 | 4 | Soni Manmeet Singh — COO, CFO and President | Sale (S): 4,711 @ $99.62 · Option exercise (M): 25,000 @ $27.32 · Sale (S): 9,326 @ $99.75 · Sale (S): 9,157 @ $101.05 · Sale (S): 16,163 @ $101.98 · Sale (S): 3,643 @ $102.73 · +4 more | EDGAR |
| 2023-06-14 | 4 | Patni Rajiv — EVP, Chief R&D Officer | Grant/award (A): 45,000 @ $0 · Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Ryder Steven — Director | Grant/award (A): 347 @ $93.61 · Grant/award (A): 1,682 @ $93.61 · Grant/award (A): 441 (derivative) @ $73.68 · Grant/award (A): 2,137 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Ruff Shamim — Director | Grant/award (A): 454 @ $93.61 · Grant/award (A): 1,682 @ $93.61 · Grant/award (A): 576 (derivative) @ $73.68 · Grant/award (A): 2,137 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Oliger Christy J. — Director | Grant/award (A): 1,682 @ $93.61 · Grant/award (A): 2,137 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | McClellan William D. Jr. — Director | Grant/award (A): 106 @ $93.61 · Grant/award (A): 1,682 @ $93.61 · Grant/award (A): 135 (derivative) @ $73.68 · Grant/award (A): 2,137 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Edwards Martin — Director | Grant/award (A): 133 @ $93.61 · Grant/award (A): 1,682 @ $93.61 · Grant/award (A): 169 (derivative) @ $73.68 · Grant/award (A): 2,137 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | McGaughy R Kent Jr — Director, 10% owner | Grant/award (A): 1,628 (derivative) @ $73.68 · Grant/award (A): 4,275 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | ROSE WILLIAM — Director, 10% owner | Grant/award (A): 4,275 (derivative) @ $0 · Grant/award (A): 1,085 (derivative) @ $73.68 | EDGAR |
| 2023-05-17 | 4 | Soni Manmeet Singh — COO, CFO and President | Sale (S): 12,440 @ $84.32 · Sale (S): 8,867 @ $84.86 · Sale (S): 200 @ $85.64 · Sale (S): 625 @ $80.93 | EDGAR |
| 2023-05-17 | 4 | Meyer Colin John — Chief Innovation Officer | Sale (S): 4,469 @ $84.76 · Sale (S): 1,139 @ $85.77 · Sale (S): 625 @ $80.94 | EDGAR |
| 2023-05-17 | 4 | Khan Samina — SVP, Chief Medical Officer | Sale (S): 288 @ $85.32 · Sale (S): 352 @ $81.37 | EDGAR |
| 2023-05-17 | 4 | Anand Bhaskar — SVP, Chief Accounting Officer | Sale (S): 950 @ $85.98 · Sale (S): 136 @ $81.10 | EDGAR |
| 2023-05-17 | 4 | Bir Dawn Carter — Chief Commercial Officer | Sale (S): 894 @ $85.09 · Sale (S): 417 @ $80.95 | EDGAR |
| 2023-05-17 | 4 | WORTLEY MICHAEL D — Chief Legal Officer | Sale (S): 894 @ $84.81 · Sale (S): 417 @ $80.99 | EDGAR |
Recent 8-K events — REATA PHARMACEUTICALS INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-09-26 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-21 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-12 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-07-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-07-28 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-07-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2023-06-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2023-06-07 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-05-10 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-01 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RETA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs